America's political divide could end if we all considered this 'Brief But Spectacular' idea
Sarita Linda Rocco / Facebook

Americans are more interested in politics than ever these days. More voted in the 2020 election than in any other in the past 100 years. Over 65% of the voting-eligible cast a ballot in the contentious fight between Joe Biden and Donald Trump.

"People are very excited and paying attention even though there are all this bad news and high 'wrong track' numbers in the country," Nancy Zdunkewicz, managing editor at Democracy Corps, told The Hill.

It's wonderful to see that a greater number of Americans are standing up to be counted and demanding their voices be heard. But it's also the symptom of a deep level of discontent many people feel about their country.


Apathy is toxic to democracy, but it's also a sign that things are going well. In a healthier America, we'd spend a lot more time focusing on the innovations, people, and culture that make this country great rather than the daily circus being performed by its political class.

America's political reawakening has also led to deeper divides between liberals and conservatives. This chasm is more than just a political fight but window dressing for a growing distaste between fellow citizens rooted in geography, class, education, and race.

via jihervas / Flickr

Throughout the entire election cycle, talking heads have repeatedly claimed that a president Joe Biden would work to "unite" and to "heal" America. While his victory was definitely a signal that the majority of Americans want to return to a less abrasive version of politics, it will do little to heal the political divide.

A Biden presidency won't stop social media from dividing people up into bubbles or suddenly change half of the country's mind on abortion.

A 2019 poll from Pew Research found that nearly 80% of Americans think the division between Republicans and Democrats is getting worse.

However, there may be hope for America if, as individuals, we take a more holistic look at how we participate in our democracy. In a new "Brief But Spectacular" take for PBS, Citizen University CEO Eric Liu shared his inspiring new way forward.

"I think people have a misconception that democracy is about voting," Liu begins. "But I think the deeper thing is how do you exercise the full breadth of your power."

Liu uses the example of his immigrant parents to show a way of participating in a democracy that goes far beyond "owning the libs" on Twitter or canceling someone for having a conservative opinion.

"They joined things. They showed up for things," he said. "They knew that to live in society is not just to retreat to your tiniest bubble. But to try to be part of something greater than yourself."

"I think one of the best ways to teach children about civic engagement is to just weave it into a mindful approach of everyday life," Liu adds.

Their work obviously paid off. Liu has worked in both the Bill Clinton and Barack Obama administrations and as the CEO of Citizen University, he creates programs on civic power and character that span age, race, region, and ideology.

via New America / Flickr

"Let's walk around our neighborhoods and let's ask questions about what we see," he continues. "Do you notice that there doesn't seem to be a bus stop where we live? Do you notice that there's only fast food stores in this neighborhood?"

"Everything we see is the external deposit of a whole bunch of internalized choices about power, about responsibility, and about what we are supposed to do to create a healthy, thriving community," Liu said.

Liu knows we have numerous problems whether it's how people of color are treated by police or the quality of our public health systems. However, instead of looking to leaders or parties, he believes we should take direct action by asking "how can I show up?"

Liu invites us to look deeper than the "visible game of partisan politics" and to investigate the "deeper game of our values" and "willingness to accept responsibility."

He calls out for a critical mass of Americans who want to change the tide of division to show up "over and over again" to "rekindle the belief that democracy can work for all of us."

As Liu illustrates, being part of a democracy is about a lot more than voting or cultivating a deeply-held set of political views that are never put into action.

In today's America, most people are paying attention to the national news and the big names from two political parties. But while most of our eyes have been affixed on Washington, there's probably a pothole at the end of the street or someone pitching a tent in the park to have somewhere to sleep.

If Americans cared a little less about their partisan identities and recast themselves and others as citizens, it'd go a long way towards cooling some of the partisan rancor. It'd probably result in a few more fixed potholes as well.

via Ted Eytan / Flickr

Photo by NeONBRAND on Unsplash

I'll never forget the exhilaration I felt as I headed into the city on July 3, 2018. My pink hair was styled. I wore it up in a high ponytail, though I left two tendrils down. Two tendrils which framed my face. My makeup was done. I wore shadow on my eyes and blush on my cheeks, blush which gave me color. Which brought my pale complexion to life. And my confidence grew each time my heels clacked against the concrete.

My confidence grew with each and every step.

Why? Because I was a strong woman. A city woman. A woman headed to interview for her dream job.

I nailed the interview. Before I boarded the bus back home, I had an offer letter in my inbox. I was a news writer, with a salary and benefits, but a strange thing happened 13 months later. I quit said job in an instant. On a whim. I walked down Fifth Avenue and never looked back. And while there were a few reasons why I quit that warm, summer day: I was a new(ish) mom. A second-time mom, and I missed my children. Spending an hour with them each day just wasn't enough. My daughter was struggling in school. She needed oversight. Guidance. She needed my help. And my commute was rough. I couldn't cover the exorbitant cost of childcare. The real reason I quit was because my mental health was failing.


Keep Reading Show less
Photo by NeONBRAND on Unsplash

I'll never forget the exhilaration I felt as I headed into the city on July 3, 2018. My pink hair was styled. I wore it up in a high ponytail, though I left two tendrils down. Two tendrils which framed my face. My makeup was done. I wore shadow on my eyes and blush on my cheeks, blush which gave me color. Which brought my pale complexion to life. And my confidence grew each time my heels clacked against the concrete.

My confidence grew with each and every step.

Why? Because I was a strong woman. A city woman. A woman headed to interview for her dream job.

I nailed the interview. Before I boarded the bus back home, I had an offer letter in my inbox. I was a news writer, with a salary and benefits, but a strange thing happened 13 months later. I quit said job in an instant. On a whim. I walked down Fifth Avenue and never looked back. And while there were a few reasons why I quit that warm, summer day: I was a new(ish) mom. A second-time mom, and I missed my children. Spending an hour with them each day just wasn't enough. My daughter was struggling in school. She needed oversight. Guidance. She needed my help. And my commute was rough. I couldn't cover the exorbitant cost of childcare. The real reason I quit was because my mental health was failing.


Keep Reading Show less
True

Each year, an estimated 1.8 million people in the United States are affected by cancer — most commonly cancers of the breast, lung, prostate, and blood cancers such as leukemia. While not everyone overcomes the disease, thanks to science, more people are surviving — and for longer — than ever before in history.

We asked three people whose lives have been impacted by cancer to share their stories – how their lives were changed by the disease, and how they're using that experience to change the future of cancer treatments with the hope that ultimately, in the fight against cancer, science will win. Here's what they had to say.

Celine Ryan, 55, engineer database programmer and mother of five from Detroit, MI

Photo courtesy of Celine Ryan

In September 2013, Celine Ryan woke up from a colonoscopy to some traumatic news. Her gastroenterologist showed her a picture of the cancerous mass they found during the procedure.

Ryan and her husband, Patrick, had scheduled a colonoscopy after discovering some unusual bleeding, so the suspicion she could have cancer was already there. Neither of them, however, were quite prepared for the results to be positive -- or for the treatment to begin so soon. Just two days after learning the news, Ryan had surgery to remove the tumor, part of her bladder, and 17 cancerous lymph nodes. Chemotherapy and radiation soon followed.

Ryan's treatment was rigorous – but in December 2014, she got the devastating news that the cancer, once confined to her colon, had spread to her lungs. Her prognosis, they said, was likely terminal.

But rather than give up hope, Ryan sought support from online research, fellow cancer patients and survivors, and her medical team. When she brought up immunotherapy to her oncologist, he quickly agreed it was the best course of action. Ryan's cancer, like a majority of colon and pancreatic cancers, had been caused by a defect on the gene KRAS, which can result in a very aggressive cancer that is virtually "undruggable." According to the medical literature, the relatively smooth protein structure of the KRAS gene meant that designing inhibitors to bind to surface grooves and treat the cancer has been historically difficult. Through her support systems, Ryan discovered an experimental immunotherapy trial at the National Institutes of Health (NIH) in Bethesda, MD., and called them immediately to see if she was eligible. After months of trying to determine whether she was a suitable candidate for the experimental treatment, Ryan was finally accepted.

The treatment, known as tumor-infiltrating lymphocyte therapy, or TIL, is a testament to how far modern science has evolved. With this therapy, doctors remove a tumor and harvest special immune cells that are found naturally in the tumor. Doctors then grow the cells in a lab over the next several weeks with a protein that promotes rapid TIL growth – and once the cells number into the billions, they are infused back into the patient's body to fight the cancer. On April 1, 2015, Ryan had her tumor removed at the NIH. Two months later, she went inpatient for four weeks to have the team "wash out" her immune system with chemotherapy and infuse the cells – all 148 billion of them – back into her body.

Six weeks after the infusion, Ryan and Patrick went back for a follow-up appointment – and the news they got was stunning: Not only had no new tumors developed, but the six existing tumors in her lungs had shrunk significantly. Less than a year after her cell infusion, in April 2016, the doctors told Ryan news that would have been impossible just a decade earlier: Thanks to the cell infusion, Ryan was now considered NED – no evaluable disease. Her body was cancer-free.

Ryan is still NED today and continuing annual follow-up appointments at the NIH, experiencing things she never dreamed she'd be able to live to see, such as her children's high school and college graduations. She's also donating her blood and cells to the NIH to help them research other potential cancer treatments. "It was an honor to do so," Ryan said of her experience. "I'm just thrilled, and I hope my experience can help a lot more people."

Patrice Lee, PhD, VP of Pharmacology, Toxicology and Exploratory Development at Pfizer

Photo courtesy of Patrice Lee

Patrice Lee got into scientific research in an unconventional way – through the late ocean explorer Jacques Cousteau.

Lee never met Cousteau but her dreams of working with him one day led her to pursue a career in science. Initially, Lee completed an undergraduate degree in marine biology; eventually, her interests changed and she decided to get a dual doctoral degree in physiology and toxicology at Duke University. She now works at Pfizer's R&D site in Boulder, CO (formerly Array BioPharma), leading a group of scientists who determine the safety and efficacy of new oncology drugs.

"Scientists focused on drug discovery and development in the pharmaceutical industry are deeply committed to inventing new therapies to meet unmet needs," Lee says, describing her field of work. "We're driven to achieve new medicines and vaccines as quickly as possible without sacrificing safety."

Among the drugs Lee has helped develop during her career, including cancer therapies, she says around a dozen are currently in development, while nine have received FDA approval — an incredible accomplishment as many scientists spend their careers without seeing their drug make it to market. Lee's team is particularly interested in therapies for brain metastases — something that Lee says is a largely unmet need in cancer research, and something her team is working on from a variety of angles. "Now that we've had rapid success with mRNA vaccine technology, we hope to explore what the future holds when applying this technology to cancers," Lee says.

But while evaluating potential cancer therapies is a professional passion of Lee's, it's also a mission that's deeply personal. "I'm also a breast cancer survivor," she says. "So I've been on the other side of things and have participated in a clinical trial."

However, seeing how melanoma therapies that she helped develop have affected other real-life cancer patients, she says, has been a highlight of her career. "We had one therapy that was approved for patients with BRAF-mutant metastatic melanoma," Lee recalls. "Our team in Boulder was graced by a visit from a patient that had benefited from these drugs that we developed. It was a very special moment for the entire team."

None of these therapies would be available, Lee says without rigorous science behind it: "Facts come from good science. Facts will drive the development of new drugs, and that's what will help patients."

Chiuying "Cynthia" Kuk (they/them) MS, 34, third-year medical student at Michigan State University College of Human Medicine

Photo courtesy of Cynthia Kuk

Cynthia Kuk was just 10 years old when they had a conversation that would change their life forever.

"My mother, who worked as a translator for the government at the time, had been diagnosed with breast cancer, and after her chemotherapy treatments she would get really sick," Kuk, who uses they/them pronouns, recalls. "When I asked my dad why mom was puking so much, he said it was because of the medicine she was taking that would help her get better."

Kuk's response was immediate: "That's so stupid! Why would a medicine make you feel worse instead of better? When I'm older, I want to create medicine that won't make people sick like that."

Nine years later, Kuk traveled from their native Hong Kong to the United States to do exactly that. Kuk enrolled in a small, liberal arts college for their Bachelor's degree, and then four years later started a PhD program in cancer research. Although Kuk's mother was in remission from her cancer at the time, Kuk's goal was the same as it had been as a 10-year-old watching her suffer through chemotherapy: to design a better cancer treatment, and change the landscape of cancer research forever.

Since then, Kuk's mission has changed slightly.

"My mom's cancer relapsed in 2008, and she ended up passing away about five years after that," Kuk says. "After my mom died, I started having this sense of urgency. Cancer research is such that you work for twenty years, and at the end of it you might have a fancy medication that could help people, but I wanted to help people now." With their mother still at the forefront of their mind, Kuk decided to quit their PhD program and enter medical school.

Now, Kuk plans to pursue a career in emergency medicine – not only because they are drawn to the excitement of the emergency room, but because the ER is a place where the most marginalized people tend to seek care.

"I have a special interest in the LGBTQ+ population, as I identify as queer and nonbinary," says Kuk. "A lot of people in this community and other marginalized communities access care through the ER and also tend to avoid medical care since there is a history of mistreatment and judgement from healthcare workers. How you carry yourself as a doctor, your compassion, that can make a huge difference in someone's care."

In addition to making a difference in the lives of LGBTQ+ patients, Kuk wants to make a difference in the lives of patients with cancer as well, like their mother had.

"We've diagnosed patients in the Emergency Department with cancer before," Kuk says. "I can't make cancer good news but how you deliver bad news and the compassion you show could make a world of difference to that patient and their family."

During their training, Kuk advocates for patients by delivering compassionate and inclusive care, whether they happen to have cancer or not. In addition to emphasizing their patient's pronouns and chosen names, they ask for inclusive social and sexual histories as well as using gender neutral language. In doing this, they hope to make medicine as a whole more accessible for people who have been historically pushed aside.

"I'm just one person, and I can't force everyone to respect you, if you're marginalized," Kuk says. "But I do want to push for a culture where people appreciate others who are different from them."